Delivery Order SPE2DR25D3101-SPE2DR26F5P55
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,355.21 to AmerisourceBergen Drug Corp for Imiquimod 5% Cream in 24-packet units. This non-competitive, firm fixed-price delivery order was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,306.88 to AmerisourceBergen Drug Corp for Imiquimod 3.75% cream (28-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,325.66 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Imiquimod 5% Cream in packets of 24 units. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Imiquimod 3.75% Cream Pump 7.5GM, with a ceiling value of $3,195.38 under firm fixed-price terms. The award was made on November 24, 2025, with an ultimate completion date of November 25, 2025. This non-set-aside competitive award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,274.31 on August 21, 2025, with an ultimate completion date of August 22, 2025. The order is for Imiquimod 3.75% cream in 28-count units, a topical immunomodulatory medication used primarily for treating certain skin conditions. This non-set-aside, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- This is a $1,560.19 firm fixed-price delivery order awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imiquimod 5% Cream Packets, with a completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which provides a comprehensive global...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Imiquimod 3.75% cream in 28-count packages, with a ceiling value of $17,482.59 and a period of performance through April 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain network to fulfill government contracts, particularly for the Department...
- The Defense Logistics Agency awarded a $403,050 delivery order to Amerisourcebergen Drug Corporation for IMIQUIMOD 5% cream packets. Under this firm fixed price contract, Amerisourcebergen will deliver 24 packets of the prescribed cream to a location in Conshohocken, Pennsylvania by August 4, 2023 to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United...
- The Defense Logistics Agency awarded a $1,473.75 firm fixed price delivery order to Amerisourcebergen Drug Corp for 3.75% imiquimod cream. As the prime contractor, Amerisourcebergen will deliver the cream to a location in Conshohocken, Pennsylvania under a single-day period of performance from July 12-13, 2023. The Defense Logistics Agency is a combat logistics support agency within the Department of Defense responsible for worldwide logistics support. This small-value delivery order is likely a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Imiquimod 3.75% Cream Pump, 7.5 gm. The $3,193.43 firm fixed-price contract has an ultimate completion date of April 18, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA)...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5P55Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,017.23 to AmerisourceBergen Drug Corp for Imiquimod 3.75% cream (28-unit package) on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single pharmaceutical delivery under AmerisourceBergen Drug Corp's broader relationship with the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. As a prime contractor on this IDC, AmerisourceBergen Drug Corp supplies pharmaceutical products and medical commodities to support military healthcare programs globally. The company's federal contracting portfolio demonstrates extensive experience fulfilling Defense Logistics Agency medical procurement requirements across diverse therapeutic domains, positioning it as a critical vendor for military and veteran healthcare system pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/23/25 |